Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Geneformics was an Israeli bioinformatics company that developed advanced IT infrastructure solutions for genomic data management. Founded in 2014, the company's core technology was a proprietary lossless compression algorithm co-developed with the Weizmann Institute of Science. This technology was specifically tuned for Next-Generation Sequencing (NGS) data, claiming to reduce the storage footprint of files such as FASTQ and BAM by up to 90% without compromising data integrity. The company offered a suite of products, including Geneformics S for on-premises servers and Geneformics D for distributed cloud environments, aimed at accelerating precision medicine workflows. Despite partnerships with major organizations like WuXi NextCODE and the Garvan Institute, the company reportedly ceased operations in early 2018.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Geneformics Data Solutions.